Sign in

NCT01790373Active, not recruiting

Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence

Suubi+Adherence: Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence

Source: ClinicalTrials.gov · Last updated 13 Jan 2026

Brief summary (registry, in English)

The goal of Suubi+Adherence is to examine the impact and cost associated with an innovative intervention to increase adherence to HIV treatment for HIV-infected adolescents. Multiple intervention studies by our team in Rakai and Masaka Districts of southern Uganda with AIDS-orphaned adolescents have revealed that if given an opportunity to participate in economic empowerment interventions, youth and their caregivers take full advantage of these interventions to save and invest in their future, show improvements in family financial outcomes, future aspirations, health functioning, sexual-risk taking behaviors, and mental health. The Suubi+Adherence study capitalizes on this prior work, positing that economic empowerment may be a missing, yet critical ingredient to HIV treatment adherence interventions for adolescents and young people. Suubi+Adherence incorporates an economic empowerment design, with a savings-led income generating component, to promote economic stability, and apply it to adherence to HIV treatment regimens for HIV-positive adolescents in a region of southern Uganda with the highest HIV incidence and prevalence in the country.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
702 (actual)
First submitted
11 Feb 2013
Start date
7 Sept 2013
Primary completion date
31 Jul 2026
Lead sponsor
Washington University School of Medicine
Diseases
HIV
NCT number
NCT01790373

What you commit to

  • Study type: Interventional
  • Participants enrolled: 702
  • From 7 Sept 2013 to the primary completion date, 31 Jul 2026
  • 2 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Not HIV-positive
  • HIV-positive but not prescribed antiretroviral therapy

Age

  • Younger than 10 years and older than 16 years

Other

  • Not enrolled in care at one of 40 medical clinics within study region
  • Not living within a family

Who the study is looking for

  • HIV-positive adolescents confirmed by medical report
  • Prescribed antiretroviral therapy
  • Enrolled in care at one of 40 medical clinics within study region
  • 10-16 years of age at the time of enrollment
  • Living within a family (not necessarily with biological parent(s))

Age in the registry: 10 years to 16 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
International Center for Child Health and Asset Development
Coordinator of this site? Confirm its status
MasakaUgandaUnknown status
Washington University in St. Louis
Coordinator of this site? Confirm its status
St LouisUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.